SANM vs SANA: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

Both stocks have similar AI ratings. Review detailed metrics below.

SANM
SANMINA CORP
SELL
72%
Confidence
VS
SANA
Sana Biotechnology, Inc.
SELL
72%
Confidence

SANM vs SANA Fundamental Comparison

Metric SANM SANA
Revenue $3.2B N/A
Net Income $49.3M $-244.2M
Net Margin 1.5% N/A
ROE 1.9% -151.8%
ROA 0.5% -58.6%
Current Ratio 1.70x 1.89x
Debt/Equity 0.82x 0.00x
EPS $0.89 $-0.96

Green = Better metric | Red = Weaker metric

View Full SANM Analysis →
View Full SANA Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

SANM vs AAPL SANA vs MSFT SANM vs GOOGL SANA vs AMZN

SANM vs SANA: Frequently Asked Questions

Is SANM or SANA a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. SANM is rated SELL (72% confidence) while SANA is rated SELL (72% confidence). This is not investment advice.

How does SANM compare to SANA fundamentally?

SANMINA CORP has ROE of 1.9% vs Sana Biotechnology, Inc.'s -151.8%. Net margins are 1.5% vs N/A respectively.

Which stock pays higher dividends, SANM or SANA?

SANM has a dividend yield of N/A or no dividend while SANA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in SANM or SANA for long term?

For long-term investing, consider that SANM has SELL rating with 72% confidence, while SANA has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about SANM vs SANA?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For SANM vs SANA, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.